Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
To the Editor—Risk factors for infectious disease severity are determined by the pathogen, host, and environment [1]. Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, includes a spectrum of illness, from asymptomatic infection [2] to severe pneumonia characterized by acute respiratory injury in about 20% of patients presenting to medical care [3]. The risk factors associated with disease severity include increased age, diabetes, immunosuppression, and organ failure [3]. Recognition of risk factors for morbidity and mortality is important to determine prevention strategies as well as to target high-risk populations for potential therapeutics. We performed a retrospective analysis of body mass index (BMI) stratified by age in COVID-19–positive symptomatic patients who presented to a large academic hospital system in New York City. Patients presenting to the emergency department (ED) with signs of respiratory distress were admitted to the hospital. Critical care was defined based on intensive care accommodation status or invasive ventilator documentation in our electronic health record. Patients who were polymerase chain reaction positive for COVID-19 during 3 March–4 April 2020 were extracted from our electronic health record system and analyzed with a χ 2 Wald test using SAS version 9.4 software (SAS Institute, Cary, North Carolina). Of the 3615 individuals who tested positive for COVID-19, 775 (21%) had a body mass index (BMI; kg/m2) 30–34, and 595 (16% of the total cohort) had a BMI ≥ 35. A total of 1853 (51%) were patients discharged from the ED, 1331 (37%) were admitted to the hospital in acute care, and 431 (12%) were either directly admitted or transferred to the intensive care unit (ICU) during admission. During analysis, we found significant differences in admission and ICU care only in patients < 60 years of age with varying BMIs (Table 1) Adult Patients Who Tested Positive for COVID-19 During 3 March–4 April 2020 (N = 3615) Abbreviations: BMI, body mass index; CI, confidence interval; COVID-19, coronavirus disease 2019; ED, emergency department; ICU, intensive care unit; OR, odds ratio. Patients aged < 60 years with a BMI between 30 and 34 were 2.0 (95% confidence interval [CI], 1.6–2.6; P < .0001) and 1.8 (95% CI, 1.2–2.7; P = .006) times more likely to be admitted to acute and critical care, respectively, compared to individuals with a BMI < 30 (Table 1). Likewise, patients with a BMI ≥ 35 and aged < 60 years were 2.2 (95% CI, 1.7–2.9; P < .0001) and 3.6 (95% CI, 2.5–5.3; P < .0001) times more likely to be admitted to acute and critical care than patients in the same age category who had BMI < 30. Though patients aged < 60 years are generally considered a lower-risk group of COVID-19 disease severity, based on data from our institution, obesity appears to be a previously unrecognized risk factor for hospital admission and need for critical care. This has important and practical implications, where nearly 40% of adults in the United States are obese with a BMI ≥ 30 [4]. The BMI range of individuals in this study appears representative of the nation, as 37% of the patients have a BMI ≥ 30. There is geographic variation in reported mortality, as South Korea, China, and Italy have reported case fatality rates of 0.8, 2.3, and 7.2, respectively [5] and regional risk factors such as prevalence of smoking, pollution, or aging population have been cited. Unfortunately, obesity in people < 60 years is a newly identified epidemiologic risk factor that may contribute to increased morbidity rates experienced in the United States. Potential conflicts of interest. The authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171 · cited 1×
“2, respectively [5] and regional risk factors such as prevalence of”
BackgroundMizumoto, K., Kagaya, K., Zarebski, A., & Chowell, G. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.10.2000180 · Cited by 2,276
Prevalence of obesity among adults, by household income and education—United States, 2011-2014.
Ogden, C. L., Fakhouri, T. H., Carroll, M. D., Hales, C. M., Fryar, C. D., Li, X., & Freedman, D. S. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6650a1 · Cited by 456
Ecological Theory to Enhance Infectious Disease Control and Public Health Policy
Smith, K. F., Dobson, A. P., McKenzie, F. E., Real, L. A., Smith, D. L., & Wilson, M. L. (2005) · Frontiers in Ecology and the Environment · doi:10.2307/3868442 · Cited by 117
Cited by
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
How mental health care should change as a consequence of the COVID-19 pandemic
Moreno, C., Wykes, T., Galderisi, S., Nordentoft, M., Crossley, N., Jones, N., Cannon, M., Correll, C. U., Byrne, L., Carr, S., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30307-2 · Cited by 1,840
Self-citationRisk factors for severe and critically ill COVID‐19 patients: A review
Gao, Y., Ding, M., Dong, X., Zhang, J., Kursat Azkur, A., Azkur, D., Gan, H., Sun, Y., Fu, W., Li, W., et al. (2021) · Allergy · doi:10.1111/all.14657 · Cited by 1,402
Popkin, B. M., Du, S., Green, W. D., Beck, M. A., Algaith, T., Herbst, C. H., Alsukait, R. F., Alluhidan, M., Alazemi, N., & Shekar, M. (2020) · Obesity Reviews · doi:10.1111/obr.13128 · Cited by 1,150
Factors associated with death in critically ill patients with coronavirus disease 2019 in the US
Gupta, S., Hayek, S. S., Wang, W., Chan, L., Mathews, K. S., Melamed, M. L., Brenner, S. K., Leonberg-Yoo, A., Schenck, E. J., Radbel, J., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.3596 · Cited by 957
Eastman, R. T., Roth, J. S., Brimacombe, K. R., Simeonov, A., Shen, M., Patnaik, S., & Hall, M. D. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00489 · Cited by 953
Beyerstedt, S., Casaro, E. B., & Rangel, É. B. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04138-6 · Cited by 897
“Approximately 50% of hospitalized COVID-19 patients have pre-existing medical conditions, including hypertension [78], diabetes mellitus (DM) [79, 80], cardiovascular disease [19, 81, 82], cerebrovascular disease [82], obesity [19, 83, 84], chronic kidney disease [19, 85], smoking [86, 87], and chronic pulmonary disea…”
BackgroundT cell responses in patients with COVID-19
Chen, Z., & John Wherry, E. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0402-6 · Cited by 797
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection
Lala, A., Johnson, K. W., Januzzi, J. L., Russak, A. J., Paranjpe, I., Richter, F., Zhao, S., Somani, S., Van Vleck, T., Vaid, A., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.06.007 · Cited by 791
“Interestingly, higher BMI was associated with increased mortality in the setting of COVID-19 among our cohort, consistent with a prior report (30).”
Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms
Sattar, N., McInnes, I. B., & McMurray, J. J. V. (2020) · Circulation · doi:10.1161/circulationaha.120.047659 · Cited by 704
Collaborative, T. O., Williamson, E., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., et al. (2020) · doi:10.1101/2020.05.06.20092999 · Cited by 6,674
“63)(6); obesity was also reported as a risk factor for treatment escalation in smaller studies in France and New York.(7,8) .”
BackgroundInfluentialZachariah, P., Johnson, C. L., Halabi, K. C., Ahn, D., Sen, A. I., Fischer, A., Banker, S. L., Giordano, M., Manice, C. S., Diamond, R., et al. (2020) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2020.2430 · Cited by 511
Bello-Chavolla, O. Y., Bahena-López, J. P., Antonio-Villa, N. E., Vargas-Vázquez, A., González-Díaz, A., Márquez-Salinas, A., Fermín-Martínez, C. A., Naveja, J. J., & Aguilar-Salinas, C. A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa346 · Cited by 493
Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 (Covid‐19)
Zhou, Y., Chi, J., Lv, W., & Wang, Y. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3377 · Cited by 490
Obesity in patients with COVID-19: a systematic review and meta-analysis
Huang, Y., Lu, Y., Huang, Y.-M., Wang, M., Ling, W., Sui, Y., & Zhao, H.-L. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154378 · Cited by 454
Association of Obesity with Disease Severity Among Patients with Coronavirus Disease 2019
Kalligeros, M., Shehadeh, F., Mylona, E. K., Benitez, G., Beckwith, C. G., Chan, P. A., & Mylonakis, E. (2020) · Obesity · doi:10.1002/oby.22859 · Cited by 442
Shi, Q., Zhang, X., Jiang, F., Zhang, X., Hu, N., Bimu, C., Feng, J., Yan, S., Guan, Y., Xu, D., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0598 · Cited by 417
Obesity aggravates COVID‐19: A systematic review and meta‐analysis
Yang, J., Hu, J., & Zhu, C. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26237 · Cited by 408
Berenguer, J., Ryan, P., Rodríguez-Baño, J., Jarrín, I., Carratalà, J., Pachón, J., Yllescas, M., Arriba, J. R., Aznar Muñoz, E., Gil Divasson, P., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.07.024 · Cited by 401
Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications
Drucker, D. J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa011 · Cited by 399
Hilbrands, L. B., Duivenvoorden, R., Vart, P., Franssen, C. F. M., Hemmelder, M. H., Jager, K. J., Kieneker, L. M., Noordzij, M., Pena, M. J., Vries, H. D., et al. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa261 · Cited by 393
Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review)
Petrakis, D., Margină, D., Tsarouhas, K., Tekos, F., Stan, M., Nikitovic, D., Kouretas, D., Spandidos, D., & Tsatsakis, A. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11127 · Cited by 388
Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide
Sanchis-Gomar, F., Lavie, C. J., Mehra, M. R., Henry, B. M., & Lippi, G. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.05.006 · Cited by 370
Diabetes, infection risk and COVID-19
Erener, S. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101044 · Cited by 351
Toussie, D., Voutsinas, N., Finkelstein, M., Cedillo, M. A., Manna, S., Maron, S. Z., Jacobi, A., Chung, M., Bernheim, A., Eber, C., et al. (2020) · Radiology · doi:10.1148/radiol.2020201754 · Cited by 343
MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19
Bilezikian, J. P., Bikle, D., Hewison, M., Lazaretti-Castro, M., Formenti, A. M., Gupta, A., Madhavan, M. V., Nair, N., Babalyan, V., Hutchings, N., et al. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0665 · Cited by 343
Bienvenu, L. A., Noonan, J., Wang, X., & Peter, K. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa284 · Cited by 338
SARS-CoV-2 and the pandemic of COVID-19
Adil, M. T., Rahman, R., Whitelaw, D., Jain, V., Al-Taan, O., Rashid, F., Munasinghe, A., & Jambulingam, P. (2021) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-138386 · Cited by 335
Prevalence of obesity among adult inpatients with COVID-19 in France
Caussy, C., Pattou, F., Wallet, F., Simon, C., Chalopin, S., Telliam, C., Mathieu, D., Subtil, F., Frobert, E., Alligier, M., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30160-1 · Cited by 334
Klang, E., Kassim, G., Soffer, S., Freeman, R., Levin, M. A., & Reich, D. L. (2020) · Obesity · doi:10.1002/oby.22913 · Cited by 330
Duarte‐Neto, A. N., Monteiro, R. A. A., da Silva, L. F. F., Malheiros, D. M. A. C., de Oliveira, E. P., Theodoro‐Filho, J., Pinho, J. R. R., Gomes‐Gouvêa, M. S., Salles, A. P. M., de Oliveira, I. R. S., et al. (2020) · Histopathology · doi:10.1111/his.14160 · Cited by 327
Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss
Kirwan, R., McCullough, D., Butler, T., Perez de Heredia, F., Davies, I. G., & Stewart, C. (2020) · GeroScience · doi:10.1007/s11357-020-00272-3 · Cited by 324
Hendren, N. S., de Lemos, J. A., Ayers, C., Das, S. R., Rao, A., Carter, S., Rosenblatt, A., Walchok, J., Omar, W., Khera, R., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.051936 · Cited by 304
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19
Ng, J. H., Hirsch, J. S., Wanchoo, R., Sachdeva, M., Sakhiya, V., Hong, S., Jhaveri, K. D., Fishbane, S., Abate, M., Andrade, H. P., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.07.030 · Cited by 295
Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study
Yang, J. M., Koh, H. Y., Moon, S. Y., Yoo, I. K., Ha, E. K., You, S., Kim, S. Y., Yon, D. K., & Lee, S. W. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.08.008 · Cited by 285
Földi, M., Farkas, N., Kiss, S., Zádori, N., Váncsa, S., Szakó, L., Dembrovszky, F., Solymár, M., Bartalis, E., Szakács, Z., et al. (2020) · Obesity Reviews · doi:10.1111/obr.13095 · Cited by 271
Giacomelli, A., Ridolfo, A. L., Milazzo, L., Oreni, L., Bernacchia, D., Siano, M., Bonazzetti, C., Covizzi, A., Schiuma, M., Passerini, M., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104931 · Cited by 262
Obesity as a predictor for a poor prognosis of COVID-19: A systematic review
Tamara, A., & Tahapary, D. L. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.05.020 · Cited by 259
Zhang, C. H., & Schwartz, G. G. (2020) · The Journal of Rural Health · doi:10.1111/jrh.12476 · Cited by 253
Singh, R., Rathore, S. S., Khan, H., Karale, S., Chawla, Y., Iqbal, K., Bhurwal, A., Tekin, A., Jain, N., Mehra, I., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.780872 · Cited by 193
Murphy, L., Markey, K., O' Donnell, C., Moloney, M., & Doody, O. (2021) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2021.05.002 · Cited by 166
Khera, A., Baum, S. J., Gluckman, T. J., Gulati, M., Martin, S. S., Michos, E. D., Navar, A. M., Taub, P. R., Toth, P. P., Virani, S. S., et al. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100009 · Cited by 143
Flaherty, G. T., Hession, P., Liew, C. H., Lim, B. C. W., Leong, T. K., Lim, V., & Sulaiman, L. H. (2020) · Tropical Diseases, Travel Medicine and Vaccines · doi:10.1186/s40794-020-00118-y · Cited by 127
Horn, D. B., Almandoz, J. P., & Look, M. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2022.2051366 · Cited by 114
Sarzani, R., Giulietti, F., Di Pentima, C., Giordano, P., & Spannella, F. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00189.2020 · Cited by 86
The effects of age and systemic metabolism on anti-tumor T cell responses
Drijvers, J. M., Sharpe, A. H., & Haigis, M. C. (2020) · eLife · doi:10.7554/elife.62420 · Cited by 69
The association between obesity and peak antibody titer response in COVID‐19 infection
Soffer, S., Glicksberg, B. S., Zimlichman, E., Efros, O., Levin, M. A., Freeman, R., Reich, D. L., & Klang, E. (2021) · Obesity · doi:10.1002/oby.23208 · Cited by 48
Rinderknecht, M. D., & Klopfenstein, Y. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00482-9 · Cited by 23
Weight stigma after bariatric surgery: A qualitative study with Brazilian women
Dimitrov Ulian, M., Fernandez Unsain, R., Rocha Franco, R., Aurélio Santo, M., Brewis, A., Trainer, S., SturtzSreetharan, C., Wutich, A., Gualano, B., & Baeza Scagliusi, F. (2023) · PLOS ONE · doi:10.1371/journal.pone.0287822 · Cited by 22
Metadata
- Authors
- Lighter, J., Phillips, M., Hochman, S., Sterling, S., Johnson, D., Francois, F., & Stachel, A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-04-09
- Volume
- 71
- Issue
- 15
- Pages
- 896-897
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W3015826289
- Cited by
- 1,225
- References
- 5
- FWCI
- 34.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.